DTNA: A Drug Target / Disease Biomarker (G1837)

Target Name: DTNA

NCBI ID: G1837

DTNA

DTNA: A Drug Target / Disease Biomarker

DTNA (double transmembrane nucleosome) is a protein that is found in the nucleus of eukaryotic cells. It is a key component of the nuclear envelope, which is the outermost layer of the cell's nucleus. The nuclear envelope helps to protect the cell's DNA and helps to regulate the flow of nutrients and waste products into and out of the cell.

DTNA is made up of four subunits that are held together by ionic bonds. The subunits of DTNA are composed of a protein core and a transmembrane domain. The protein core of DTNA is responsible for the protein's three-dimensional structure and functions as a binding site for other molecules. The transmembrane domain of DTNA is responsible for the protein's ability to interact with the nuclear envelope and for helping to regulate the flow of nutrients and waste products into and out of the cell.

DTNA is involved in many different cellular processes in eukaryotic cells. For example, it is involved in the regulation of gene expression, DNA replication, and the cell cycle. It is also involved in the regulation of cell adhesion, and in the development and progression of cancer.

One of the most promising applications for DTNA is as a drug target. Because DTNA is involved in many different cellular processes, it is a potential target for a wide range of drugs. For example, drugs that can inhibit the activity of DTNA could be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In addition to its potential as a drug target, DTNA is also a potential biomarker. Because it is a protein that is found in the nucleus of eukaryotic cells, it is a good candidate for use as a biomarker for a variety of diseases. For example, DTNA levels could be used to track the effectiveness of cancer treatments, or to monitor the progression of neurodegenerative diseases.

Overall, DTNA is a protein that is important for many different cellular processes in eukaryotic cells. Its role in these processes makes it a potential drug target and a potential biomarker. Further research is needed to fully understand the function of DTNA and its potential applications.

Protein Name: Dystrobrevin Alpha

Functions: May be involved in the formation and stability of synapses as well as being involved in the clustering of nicotinic acetylcholine receptors

The "DTNA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DTNA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets